Rx for Weight Loss: A Closer Look Series "Controversies & Future of GLP-1 Medications"
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Rx for Weight Loss: A Closer Look Series "Controversies & Future of GLP-1 Medications"
-
ナレーター：
-
著者：
概要
Host: Darryl S. Chutka, M.D.
Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B.
The class of medications known as the GLP-1 agonists is very popular with our patients. Although initially indicated for management of diabetes, they’re frequently taken for the weight loss they commonly produce. How long should these medications be taken? Is there anything we can do to help maintain the weight loss achieved with these medications? How significant is the loss of muscle mass which can occur as part of the weight lost with these medications and can this be minimized. Finally, how safe are the compounded and unapproved versions of these medications patients often find more affordable? These are a few of the questions we’ll address in podcast on the GLP-1 medications used for weight loss and we’ll tackle the “Controversies and Future of the GLP-1 Medications”. My guests include Dr. Meera Shah and Dr. Tamim Rajjo, both from the Division of Endocrinology at the Mayo Clinic.
Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts